NeuSpera Medical said yesterday it raised $8 million in a new round of equity financing to support its injectable neuromodulation devices.
NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology.
The Santa Clara, Calif.-based company says its implantable module is 100 times smaller than other neuromodulation devices.
The money came from 3 anonymous investors, according to an SEC filing, and the company has not yet said how it intends to use the funds raised during the round. Previous to this most recent round of financing, NeuSpera said it had raised more than $1 million in angel funding.
In August, NeuSpera Medical said it snagged the former R&D senior vice president at Cyberonics, Milton Morris, for its corner office as it geared up to raise a Series A round for its neuromodulation technology.
The post NeuSpera raises $8m for injectable neuromod devices appeared first on MassDevice.